Clinical characteristics of patients with hepatitis and cirrhosis and the construction of a prediction model

Table 3 Logistic regression analysis of risk factors for hepatitis cirrhosis

	B	SE	Wals	P value	OR	95%CI
Alb	-0.033	0.043	0.608	0.736	0.967	0.890 to 1.052
LDH	-0.002	0.002	1.211	0.271	0.998	0.993 to 1.002
CHE	0.000	0.000	1.565	0.211	1.000	1.000 to 1.000
GOT/GPT	0.640	0.305	4.401	0.036	1.896	1.043 to 3.448
INR	14.952	9.843	2.307	0.129	2.536	0.013 to 7.450
PT	-1.566	0.877	3.184	0.074	0.209	0.037 to 1.167
PTA	-0.049	0.022	5.252	0.022	0.952	0.913 to 0.993
HBeAg	-0.001	0.000	5.310	0.021	0.999	0.999 to 1.000
HA	0.000	0.001	0.088	0.767	1.000	0.998 to 1.003
LN	0.000	0.004	0.015	0.901	1.000	0.992 to 1.007
PLT	0.000	0.000	0.574	0.449	1.000	1.000 to 1.000
WBC	-1.527	0.794	3.701	0.054	0.217	0.046 to 1.029
RBC	-0.311	0.586	0.281	0.596	0.733	0.233 to 2.310
HGB	0.027	0.018	2.129	0.145	1.027	0.991 to 1.065
ANC	1.302	0.864	2.268	0.132	3.676	0.676 to 20.002
ALC	0.963	0.831	1.341	0.247	2.619	0.513 to 13.364
Constant	6.572	5.590	1.382	0.240	715.135

OR: Odds ratio; CI: Confidence interval; Alb: Albumin; LDH: Lactate dehydrogenase; CHE: Cholinesterase; WBC: White blood cell; RBC: Red blood cell; HGB: Hemoglobin; ANC: Absolute neutrophil count; ALC: Absolute lymphocyte count; PTA: Prothrombin activity; GOT: Aspartate aminotransferase; GPT: Alanine aminotransferase; HBeAg: Hepatitis B E antigen; INR: International normalized ratio; PT: Plasma prothrombin time; HA: Hyaluronic acid; LN: Laminin; PLT: Platelet count.